These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 3229666)

  • 1. Relative prognostic significance of DNA flow cytometry and histologic grading in endometrial carcinoma.
    Quillamor RM; Furlong JW; Hoschner JA; Wynn RM
    Gynecol Obstet Invest; 1988; 26(4):332-7. PubMed ID: 3229666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA ploidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues.
    Takahashi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1339-44. PubMed ID: 1700035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric DNA analysis of normal and cancerous human endometrium and cytological-histopathological correlations.
    Lindahl B; Alm P; Killander D; Långström E; Tropé C
    Anticancer Res; 1987; 7(4B):781-9. PubMed ID: 3674763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors].
    Shimizu K
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Flow cytometric DNA analysis of uterine endometrial carcinoma].
    Izumi S; Yamaoka K; Arai H; Watanabe T; Tsutsui F; Tamura S; Nozawa S; Kurihara S
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):722-8. PubMed ID: 1890350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Flow cytometric evaluation of DNA ploidy pattern in uterine cancer].
    Watanabe T; Izumi S; Yamaoka K; Tsutsui F; Nozawa S
    Nihon Rinsho; 1992 Oct; 50(10):2432-8. PubMed ID: 1447814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA content and its relationship with pathology and prognosis of colorectal carcinoma.
    Jiang B; Liu CG; Wang MW; Zhao DH; Li Y; Ji XL
    Chin Med J (Engl); 1992 Mar; 105(3):241-6. PubMed ID: 1395845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relationship between DNA content in cervical carcinoma cell and the clinicopathological features].
    Zhang H
    Zhonghua Bing Li Xue Za Zhi; 1989 Jun; 18(2):137-9. PubMed ID: 2582553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age, menopausal status and DNA-content in endometrial adenocarcinoma.
    Strang P; Stendahl U; Tribukait B; Wagenius G; Boman K
    Anticancer Res; 1989; 9(4):1079-82. PubMed ID: 2817789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA ploidy in endometrial carcinoma: major objective prognostic factor.
    Britton LC; Wilson TO; Gaffey TA; Cha SS; Wieand HS; Podratz KC
    Mayo Clin Proc; 1990 May; 65(5):643-50. PubMed ID: 2348728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial adenocarcinoma. A multiparameter clinicopathologic analysis including the DNA profile and the sex steroid hormone receptors.
    Geisinger KR; Homesley HD; Morgan TM; Kute TE; Marshall RB
    Cancer; 1986 Oct; 58(7):1518-25. PubMed ID: 3742470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric deoxyribonucleic acid index: a prognostic factor in endometrial carcinoma.
    Iversen OE
    Am J Obstet Gynecol; 1986 Oct; 155(4):770-6. PubMed ID: 3766632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Flow cytometric DNA analysis of gynecologic malignant tumors using paraffin-embedded tissue].
    Tase T; Oikawa N; Toki T; Wada Y; Yajima A
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):87-91. PubMed ID: 3546533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric analysis of uterine sarcoma: ploidy and S-phase rate as prognostic indicators.
    Malmström H; Schmidt H; Persson PG; Carstensen J; Nordenskjöld B; Simonsen E
    Gynecol Oncol; 1992 Feb; 44(2):172-7. PubMed ID: 1544595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dna ploidy in adenocarcinoma of Barrett's esophagus].
    Flejou JF; Doublet B; Potet F; Metayer J; Hemet J
    Ann Pathol; 1990; 10(3):161-5. PubMed ID: 2386598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methodological aspects on cytochemical DNA assessment of adenocarcinoma of the endometrium by means of image and flow cytometry using conventionally formalin-fixed and paraffin-embedded specimens.
    Askensten U; Moberger B; Auer G
    Arch Geschwulstforsch; 1990; 60(3):209-16. PubMed ID: 1695087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flow cytometric DNA measurements of thyroid carcinomas].
    Tsuchiya A; Sekikawa K; Kimijima I; Suzuki S; Nihei M; Rokkaku Y; Abe R
    Gan No Rinsho; 1989 Jul; 35(8):886-90. PubMed ID: 2746864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric DNA-ploidy as a prognostic indicator in oral squamous cell carcinoma.
    Wang XL; Chen RM; Wang ZS; Chen WL; Zuo LF
    Chin Med J (Engl); 1990 Jul; 103(7):572-5. PubMed ID: 2119974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA content is an independent prognostic indicator in endometrial adenocarcinoma. A Gynecologic Oncology Group study.
    Zaino RJ; Davis AT; Ohlsson-Wilhelm BM; Brunetto VL
    Int J Gynecol Pathol; 1998 Oct; 17(4):312-9. PubMed ID: 9785131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.